KB-121

N/A

Report date: 2025/01/26 15:14:13

Base Information

Drug NameKB-121
Drug Alias NameTfR1 inhibitor (Gemopharm)KB-121
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionTransferrin receptor protein 1 antagonists
TargetsTransferrin receptor protein 1
Therapy Area/IndicationsMultiple MyelomaLymphoma, Mantle-CellLymphoma, Large B-Cell, Diffuse +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryRussian Federation
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGEMOPHARM LLC
China Registration ClassN/A

Develop Information

Active CompaniesGEMOPHARM LLC
Inactive CompaniesN/A
Active IndicationsMultiple MyelomaLymphoma, Mantle-CellLymphoma, Large B-Cell, Diffuse +[5] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A